Hengyi Petrochemical stock
000703.SZSHZHengyi Petrochemical Co., Ltd., Basic MaterialsISIN CNE0000001J1
54Score 54 out of 100, Neutral
Price and trend
52 / 100
Price history
+64% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 18% below it.
Since September 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 34).
The price is 43% below its 52-week high. Largest decline in 20 years: 86% (September 2007 to November 2008).
Chart figures for advanced users
- SMA 50$2.32
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$2.17
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)34
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$0.97
- The lowest closing price of the last twelve months.
- Resistance$3.12
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Hengyi Petrochemical Co., Ltd. belongs to the Chemicals (Specialty) industry (China) and, with a market value of $6.93B, is number 43 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $17.02B (down 9.5% year on year) and earnings of $38.73M (up 10.4%).
- For fiscal 2026, analysts expect on average revenue of $21.98B (up 29.2%) and adjusted earnings per share of $0.37 (up 3,845.2%).
Show more
- MEQIRI Score 54 out of 100 (Neutral): rank 275 of 467 in Basic Materials, median 58.
- The P/E is 5.5 (Chemicals (Specialty) median 20.2, own median of recent years 22.4).
- Our model puts fair value at $3.79, with the price 52% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Modestly valuedP/E 5.5, Chemicals (Specialty) median 20.2, own median 22.4.Valuation 95
- Share buybacksShare count down 12% since 2020.
Weaknesses
- Earnings per share fallingDown 37.5% a year since 2020.
- Interest barely coveredOperating profit covers interest only 1.2 times.Stability 27
- High debtDebt 1.7 times equity (latest quarter), Chemicals (Specialty) median 0.29.Stability 27
Its standout strengths are valuation and growth, while capital allocation and stability hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 53 to 54.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Possible value trapClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $2.53 and expensive above $7.59 (uncertainty very high, based on the price swings of the past year).
The two parts of the fair value come to $1.03 (cash-flow model) and $6.56 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 11.7%. At 12.7% the fair value would be $3.74, at 10.7% it would be $3.86.
Possible value trap: looks cheap, but high risk.
Valuation metrics
Half from the dividend model, half from earnings times the industry P/E (20.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 20.5% on the twelve months before. Revenue has grown strongly since 2006, at around 37% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 5%, operating 0%, net 0%. Last 12 months: net 6%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 22 Apr 2027in 161 days
- Last reported
- 26 Oct 2026EPS reported $0.09
Analyst estimates
Earnings estimates have barely changed since 28 Oct 2026.
- Earnings per share
- $0.37+1.0%
- Revenue
- $21.98B+1.1%
- Earnings per share
- $0.34+0.2%
- Revenue
- $22.69B−0.3%
MEQIRI has stored the estimates since 28 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Hengyi Petrochemical
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 54
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- SRFSRF.NS $7.94B59
- Axalta Coating SystemsAXTA $7.93B71
- Eastman ChemicalEMN $7.6B60
- China Rare Earth Resources and Technology000831.SZ $7.57B52
- Huafon Chemical002064.SZ $6.92B60
- IMCDIMCD.AS $6.72B65
- Shanghai Putailai New Energy Technology603659.SS $6.6B58
- SOLSOL.MI $6.42B68
ETFs that hold Hengyi Petrochemical
Held by 25 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| WisdomTree Emerging Markets Equity Income UCITS ETF AccWTD8 | 0.14% | 0.46% | €256.08M |
| Amundi MSCI China A UCITS ETF AccCNAA | 0.10% | 0.35% | €83.52M |
| Franklin FTSE China UCITS ETFFLXC | 0.02% | 0.19% | €1.3B |
Show 5 more
| HSBC MSCI China UCITS ETFH4ZP | 0.02% | 0.28% | €865.21M |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.01% | 0.17% | €5.24B |
| HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF USDH411 | 0.00% | 0.45% | €400.29M |
| iShares Core MSCI EM IMI UCITS ETFIS3N | 0.00% | 0.18% | €37.17B |
| UBS Core MSCI EM UCITS ETF USD disUIMI | 0.00% | 0.15% | €10.33B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = CN¥6.6707)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.